Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database

por Wang, Shuai, Jayarangaiah, Apoorva, Malone, Mariuxi, Elrafei, Tarek, Steinberg, Lewis, Kumar, Abhishek
Publicado 2020